Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 9, 2020 - Osmotica Pharmaceuticals announced the FDA approval of Upneeq (oxymetazoline), for the treatment of acquired blepharoptosis in adults.
Download PDF
Return to publications
